drugset / Trial / NCT04045379

LASER and Radiofrequency and Genitourinary Syndrome of Menopause

NCT04045379

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative radiofrequency and topic strogen to treat symptoms of vulvovaginal atrophy of post menopause.

Timeline

Start
2019-08-05
Primary completion
2025-08
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estriol Unknown 1 mg/ml Other